# Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma

> **NCT02046187** · PHASE1,PHASE2 · TERMINATED · sponsor: **St. Joseph's Hospital and Medical Center, Phoenix** · enrollment: 14 (actual)

## Conditions studied

- Glioblastoma (GBM)

## Interventions

- **DIETARY_SUPPLEMENT:** Ketogenic Diet
- **RADIATION:** Radiation therapy
- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT02046187
- **Lead sponsor:** St. Joseph's Hospital and Medical Center, Phoenix
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-10
- **Primary completion:** 2017-02
- **Final completion:** 2017-02
- **Target enrollment:** 14 (ACTUAL)
- **Why stopped:** excessive protocol deviations due to strict nature of diet requirements
- **Last updated:** 2021-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02046187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02046187, "Ketogenic Diet With Radiation and Chemotherapy for Newly Diagnosed Glioblastoma". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02046187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*